The main market opportunities arise from enhancing supply chain integrity in the pharmaceutical industry through GDP and GSP compliance. This addresses regulatory adherence, quality assurance, and ...
Key market opportunities include enhancing quality systems in the pharmaceutical supply chain, robust implementation of Good Distribution Practice (GDP), and combating counterfeit drug threats.
The "Good Distribution Practices of Pharmaceuticals and APIs Training Course (Nov 17th - Nov 18th, 2025)" training has been added to ResearchAndMarkets.com's offering. It is crucial that ...
AIT Worldwide Logistics' Life Sciences Control Tower earns Good Distribution Practices certification
ITASCA, Ill., Sept. 26, 2019 /PRNewswire/ -- AIT Worldwide Logistics' life sciences division recently received Good Distribution Practice (GDP) certification for its central hub in Itasca, Ill., from ...
Global air services provider and UK’s leading ground handler, Dnata, has been awarded certification for Good Distribution Practice (GDP) by the UK Medicines and Healthcare Products Regulatory Agency ...
The Drugs Technical Advisory Board (DTAB), which recommends on policy decisions related to technical matters on the Drugs and Cosmetics Act and relevant rules, has given its green signal to amend the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results